指南与共识心脑血管急症重症综合管理与镇静镇痛

EAPCI立场声明:COVID-19大流行期间急性冠脉综合征的侵入性管理

EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic.
指南 / 共识 · EuroIntervention · 2020-01-01
一句话结论EAPCI联合ACVC发布立场声明,提出COVID-19大流行期间ST段抬高与非ST段抬高型ACS患者的改良诊断与治疗流程、ACS网络重组及导管室防护措施。

该立场声明由欧洲经皮心血管介入协会(EAPCI)与急性心血管护理协会(ACVC)任命的介入心脏病学家和急性心脏护理专家小组制定,纳入欧洲首批及疫情最严重地区的经验。声明针对确诊或疑似COVID-19感染的ST段抬高型和非ST段抬高型ACS患者,提出改良的诊断与治疗算法,以在疫情挑战下调整循证方案。同时涵盖ACS网络重组(hub与spoke医院重新分配)、急诊室与心脏单元院内重组、导管室重组以及侵入性操作中医护人员防护措施,并附多个欧洲国家的示例。

要点

  • 声明针对确诊或疑似COVID-19感染的ST段抬高型和非ST段抬高型ACS患者,提出改良的诊断与治疗算法。
  • 声明提出ACS网络重组需求,包括hub与spoke医院的重新分配。
  • 声明涵盖急诊室与心脏单元的院内重组,并附多个欧洲国家示例。
  • 声明提供导管室重组指导及侵入性操作中医护人员防护措施。
  • 声明由EAPCI与ACVC任命的介入心脏病学家和急性心脏护理专家小组制定,纳入欧洲首批及最严重受影响地区的经验。

适用人群与场景

  • 确诊或疑似COVID-19感染、表现为ST段抬高型ACS的患者。
  • 确诊或疑似COVID-19感染、表现为非ST段抬高型ACS的患者。

处置流程与药物剂量

  • 对确诊或疑似COVID-19感染的ST段抬高型和非ST段抬高型ACS患者,采用声明提出的改良诊断与治疗算法。
  • 对ACS网络进行重组,包括hub与spoke医院的重新分配。
  • 对急诊室与心脏单元进行院内重组。
  • 对导管室进行重组,并采取侵入性操作中医护人员的防护措施。

研究设计与关键结果

  • 声明由EAPCI与ACVC任命的介入心脏病学家和急性心脏护理专家小组制定,纳入欧洲首批及最严重受影响地区的经验。
  • 声明描述了确诊或疑似COVID-19感染的ST段抬高型和非ST段抬高型ACS患者的各种临床场景及管理算法。
  • 声明提供来自多个欧洲国家的ACS网络重组、急诊室与心脏单元院内重组示例。

证据类型、等级与局限

  • 证据类型:EAPCI与ACVC立场声明(专家小组制定)。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 声明提出对确诊或疑似COVID-19感染的ST段抬高型和非ST段抬高型ACS患者采用改良诊断与治疗算法,以在疫情下调整循证方案。
  • 声明提出重组ACS网络(hub与spoke医院重新分配)、急诊室与心脏单元院内重组、导管室重组及侵入性操作中医护人员防护。

指南或共识出处

  • EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic(EAPCI立场声明,EuroIntervention)

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

The coronavirus disease 2019 (COVID-19) pandemic poses an unprecedented challenge to healthcare worldwide. The infection can be life threatening and require intensive care treatment. The transmission of the disease poses a risk to both patients and healthcare workers. The number of patients requiring hospital admission and intensive care may overwhelm health systems and negatively affect standard care for patients presenting with conditions needing emergency interventions. This position statements aims to assist cardiologists in the invasive management of acute coronary syndrome (ACS) patients in the context of the COVID-19 pandemic. To that end, we assembled a panel of interventional cardiologists and acute cardiac care specialists appointed by the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and from the Acute Cardiovascular Care Association (ACVC) and included the experience from the first and worst affected areas in Europe. Modified diagnostic and treatment algorithms are proposed to adapt evidence-based protocols for this unprecedented challenge. Various clinical scenarios, as well as management algorithms for patients with a diagnosed or suspected COVID-19 infection, presenting with ST- and non-ST-segment elevation ACS are described. In addition, we address the need for re-organization of ACS networks, with redistribution of hub and spoke hospitals, as well as for in-hospital reorganization of emergency rooms and cardiac units, with examples coming from multiple European countries. Furthermore, we provide a guidance to reorganization of catheterization laboratories and, importantly, measures for protection of healthcare providers involved with invasive procedures.

来源:EuroIntervention,查看原文。版权归原作者所有。

参考来源

  1. Chieffo A, Stefanini GG, Price S, et al. EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic. EuroIntervention. 2020. PMID: 32404302. doi:10.4244/EIJY20M05_01

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。